News

Calcium Antagonists Market Projected To Gain a Revolutionary Growth

Calcium antagonists are a group of medications that disrupt the movement of calcium (Ca2+) through calcium channels. Calcium channel blockers are used as antihypertensive drugs, i.e., as medications to decrease blood pressure in patients with hypertension. CCBs are particularly effective against large vessel stiffness, one of the common causes of elevated systolic blood pressure in elderly patients. Calcium channel blockers are also frequently used to alter heart rate (especially from atrial fibrillation), to prevent peripheral and cerebral vasospasm, and to reduce chest pain caused by angina pectoris.

N-type, L-type, and T-type voltage-dependent calcium channels are present in the zona glomerulosa of the human adrenal gland, and CCBs can directly influence the biosynthesis of aldosterone in adrenocortical cells, with consequent impact on the clinical treatment of hypertension with these agents.

CCBs have been shown to be slightly more effective than beta blockers at lowering cardiovascular mortality, but they are associated with more side effects. Potential major risks however were mainly found to be associated with short-acting CCBs.

This report contains market size and forecasts of Calcium Antagonists in global, including the following market information:

Global Calcium Antagonists Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Calcium Antagonists Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Calcium Antagonists companies in 2021 (%)

The global Calcium Antagonists market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Dihydropyridine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Calcium Antagonists include Pfizer, Aventis, Searle, Bayer, AstraZeneca, Knoll Pharmaceuticals, Wyeth-Ayerst, Novartis and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Calcium Antagonists manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Calcium Antagonists Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Calcium Antagonists Market Segment Percentages, by Type, 2021 (%)

  • Dihydropyridine
  • Diltiazem
  • Verapamil
  • Others

Global Calcium Antagonists Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Calcium Antagonists Market Segment Percentages, by Application, 2021 (%)

  • Hypertension
  • Coronary Artery Disease
  • Arrhythmia
  • Ohers

Global Calcium Antagonists Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Calcium Antagonists Market Segment Percentages, By Region and Country, 2021 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Calcium Antagonists revenues in global market, 2017-2022 (Estimated), ($ millions)
  • Key companies Calcium Antagonists revenues share in global market, 2021 (%)
  • Key companies Calcium Antagonists sales in global market, 2017-2022 (Estimated), (K Units)
  • Key companies Calcium Antagonists sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • Pfizer
  • Aventis
  • Searle
  • Bayer
  • AstraZeneca
  • Knoll Pharmaceuticals
  • Wyeth-Ayerst
  • Novartis
  • Sanofi
  • Baiyunshan Pharmaceutical
  • South China Pharmaceutical Group
  • Tianjin Tanabe Seiyaku

Table of content

1 Introduction to Research & Analysis Reports
1.1 Calcium Antagonists Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Calcium Antagonists Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Calcium Antagonists Overall Market Size
2.1 Global Calcium Antagonists Market Size: 2021 VS 2028
2.2 Global Calcium Antagonists Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Calcium Antagonists Sales: 2017-2028
3 Company Landscape
3.1 Top Calcium Antagonists Players in Global Market
3.2 Top Global Calcium Antagonists Companies Ranked by Revenue
3.3 Global Calcium Antagonists Revenue by Companies
3.4 Global Calcium Antagonists Sales by Companies
3.5 Global Calcium Antagonists Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Calcium Antagonists Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Calcium Antagonists Product Type
3.8 Tier 1, Tier 2 and Tier 3 Calcium Antagonists Players in Global Market
3.8.1 List of Global Tier 1 Calcium Antagonists Companies
3.8.2 List of Global Tier 2 and Tier 3 Calcium Antagonists Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Calcium Antag

CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414

Similar Reports:

Global Calcium Antagonists Sales Market Report 2021

Global Calcium Antagonists Market Research Report 2021

Global Calcium Antagonists Market Research Report 2020

Global Calcium Antagonists Market Insight and Forecast to 2026

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button